- Abstract
- Core Tip
- Full Article (PDF)
- Full Article with Cover (PDF)
- Full Article (XML)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (1598)
- Timeline of Article Publication (3)
- Authors Evaluation (5)
- Article Quality Tracking (2)
- Reference Citation Analysis (7)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2297)
All Articles published online
|
Publishing Process of This Article
|
Feb 15, 2024 (publication date) through Jul 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Pan D, Liu HN, Qu PF, Ma X, Ma LY, Chen XX, Wang YQ, Qin XB, Han ZX. Progress in the treatment of advanced hepatocellular carcinoma with immune combination therapy. World J Gastrointest Oncol 2024; 16(2): 273-286 [PMID: 38425407 DOI: 10.4251/wjgo.v16.i2.273] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i2/273.htm |
| Number | Citing Articles |
| 1 |
JieYu Li, WanSong Lin, TianYing Huang, MingShui Chen, QiaoYan Lin. IL-12 improves the anti-HCC efficacy of dendritic cells loaded with exosomes from overexpressing Rab27a tumor cells. Experimental Cell Research 2024; 439(1): 114073 doi: 10.1016/j.yexcr.2024.114073
|
| 2 |
Yamei Huang, Min Peng, Weiping Yu, Hui Li. Activation of Wnt/β-catenin signaling promotes immune evasion via the β-catenin/IKZF1/CCL5 axis in hepatocellular carcinoma. International Immunopharmacology 2024; 138: 112534 doi: 10.1016/j.intimp.2024.112534
|
| 3 |
Jiuliang Jiang, Pingping Yang, Xinyu Xu, Huixiong Yuan, Haitao Zhu. Donafenib inhibits PARP1 expression and induces DNA damage, in combination with PARP1 inhibitors promotes apoptosis in liver cancer cells. Anti-Cancer Drugs 2024; doi: 10.1097/CAD.0000000000001631
|